Učitavanje...
Osimertinib in the treatment of non-small-cell lung cancer: design, development and place in therapy
The discovery of epidermal growth factor receptor (EGFR) mutations and subsequent demonstration of the efficacy of genotype-directed therapies with EGFR tyrosine kinase inhibitors (TKIs) marked the advent of the era of precision medicine for non-small-cell lung cancer (NSCLC). First- and second-gene...
Spremljeno u:
| Izdano u: | Lung Cancer (Auckl) |
|---|---|
| Glavni autori: | , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5571822/ https://ncbi.nlm.nih.gov/pubmed/28860885 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/LCTT.S119644 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|